Ther­mo Fish­er reels in pro­teomics com­pa­ny Olink in $3.1B deal

Ther­mo Fish­er is set to in­crease its pro­teomics of­fer­ing through the pur­chase of Olink in a deal worth $3.1 bil­lion.

The Swedish com­pa­ny, which start­ed in 2016, of­fers a suite of pro­teomics-based ser­vices de­signed to help phar­ma com­pa­nies and aca­d­e­m­ic re­searchers in their pro­tein bio­mark­er dis­cov­ery and drug de­vel­op­ment. Olink’s $OLK share price jumped 65% up­on the an­nounce­ment.

The con­glom­er­ate’s buy­out pro­pos­al val­ues Olink at $26 per com­mon share, which is about 74% of the pro­teom­ic play­er’s clos­ing price on Mon­day. The $3.1 bil­lion ten­der of­fer fac­tors in $143 mil­lion in cash that Olink al­ready has. Olink’s rev­enue is cur­rent­ly pro­ject­ed to ex­ceed $200 mil­lion next year, ac­cord­ing to a press re­lease.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.